Traws Pharma Inc (TRAW): Earnings per share for the last twelve months

Corporate company logo of trawspharma.com (TRAW)

Traws Pharma, Inc. (TRAW) allocates significant resources to R&D, which increases costs during scaling. Business growth depends on clinical outcomes rather than GDP, ensuring macroeconomic resilience. The TTM earnings per share trend reflects real-time assessments, where the current mark equals -2.31. Meanwhile, the company is implementing green chemistry principles for the safe disposal of reagents.

Traws Pharma, Inc. (TRAW) - Net earnings per share (EPS TTM) from 04/04/2024 to 11/15/2026

Traws Pharma, Inc. (TRAW) - metric breakdowns and financial figures

- stock price and consensus target price:
- stock exchange capitalization data:
General company analysis:Traws Pharma (TRAW)
Flagship merchandise of Traws Therapeutics

Traws Pharma, Inc. (TRAW) maintains stability through synergy with government institutions in the development of antiviral drugs. This rolling 12-month EPS chart reflects net income allocated per share, excluding short-term volatility. This indicator measures real capitalization efficiency through the lens of specific yield. Growing metrics confirm the successful funding of clinical phases. The positive trend of this metric justifies the asset's fair market value.

Competitors of Traws Pharma, Inc. (TRAW)

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Vir Biotechnology (VIR) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months SIGA Technologies Inc (SIGA)|EBS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) AVIR (Atea Pharma)|Net earnings per share for the last four quarters Invivyd, Inc. (IVVD)|ENTA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Inovio|HilleVax (HLVX) - Earnings per share for the last twelve months|KLRS (Kalaris Therapeutics) - Earnings per share for the last twelve months|DYAI (Dyadic International, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NanoViricides NNVC|Net earnings per share (EPS TTM) TLPH|COCP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters